New Stock News | Wanmei Biological (603983.SH) submits application to Hong Kong Exchange, becoming the third largest beauty and cosmetics company in China specializing in reforming collagen protein skincare products.

According to the Zhidao Financial APP, as disclosed by the Hong Kong Stock Exchange on December 11th, Guangdong Wanmei Biotechnology Co., Ltd. (603983.SH) has submitted an application to the main board of the Hong Kong Stock Exchange for listing, with Goldman Sachs and CITIC Securities as its joint sponsors. The prospectus shows that, based on a Frost & Sullivan report, Wanmei Biotechnology is the third largest cosmetics company in China in the field of recombinant collagen skincare products based on retail sales in 2024.